Back to Results
First PageMeta Content
Benzimidazoles / Pyridines / Sulfoxides / Organic chemistry / Gastroenterology / Omeprazole / Helicobacter pylori eradication protocols / Rabeprazole / Helicobacter pylori / Medicine / Proton pump inhibitors / Chemistry


News Release Takeda Pharmaceutical Company Limited AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation Eisai Co., Ltd. Helicobacter pylori Gastritis Approved as Additional Indication in Japan for Helicobacter pylori
Add to Reading List

Document Date: 2013-02-20 20:53:02

Open Document

File Size: 39,12 KB

Share Result on Facebook

City

Tokyo / Osaka / /

Company

Ohara Pharmaceutical Co. Ltd. / Taisho Pharmaceutical Co. Ltd. / Eisai Co. Ltd. / Kyowa Hakko Kirin Co. Ltd. / Takeda Pharmaceutical Company Limited / Shionogi & Co. Ltd. / Abbott Japan Co. Ltd. / Mitsubishi Tanabe Pharma Corporation / Takata Seiyaku Co. Ltd. / Mylan Inc. / Astellas Pharma Inc. / AstraZeneca K.K. Mitsubishi Tanabe Pharma Corporation / News Release Takeda Pharmaceutical Company Limited / /

Country

Japan / /

IndustryTerm

respective applications / /

MedicalCondition

gastric and duodenal ulcers / early-stage gastric cancer / H. pylori infection / H. pylori gastritis / gastric MALT lymphoma / gastritis / diseases / inflammatory cells / idiopathic thrombocytopenic purpura / histological gastric mucosal injury / /

Organization

Japan Gastroenterological Endoscopy Society / Japanese Society for Helicobacter Research / Japanese Society of Gastroenterology / Ministry of Health / /

Person

Michihiro Tsuchiya / Labour / Paul Hudson / /

Position

President / President and CEO / Minister of Health / President & CEO / /

Product

Flagyl / rabeprazole sodium / esomeprazole magnesium / Nexium / Na Tablets / OD Tablets / metronidazole / amoxicillin / lansoprazole / clarithromycin / omeprazole / Rabeprazole / /

SocialTag